AAAAAA
Results:
1-25
|
Results: 25
Authors:
Gerlag, DM
Borges, E
Tak, PP
Ellerby, HM
Bredesen, DE
Pasqualini, R
Ruoslahti, E
Firestein, GS
Citation: Dm. Gerlag et al., Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature, ARTHRITIS R, 3(6), 2001, pp. 357-361
Authors:
Yi, M
Ruoslahti, E
Citation: M. Yi et E. Ruoslahti, A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis, P NAS US, 98(2), 2001, pp. 620-624
Authors:
Matter, ML
Ruoslahti, E
Citation: Ml. Matter et E. Ruoslahti, A signaling pathway from the alpha(5)beta 1 and alpha(v)beta(3) integrins that elevates bcl-2 transcription, J BIOL CHEM, 276(30), 2001, pp. 27757-27763
Authors:
McLean, GW
Brown, K
Arbuckle, MI
Wyke, AW
Pikkarainen, T
Ruoslahti, E
Frame, MC
Citation: Gw. Mclean et al., Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis, CANCER RES, 61(23), 2001, pp. 8385-8389
Authors:
Assa-Munt, N
Jia, X
Laakkonen, P
Ruoslahti, E
Citation: N. Assa-munt et al., Solution structures and integrin binding activities of an RGD peptide withtwo isomers, BIOCHEM, 40(8), 2001, pp. 2373-2378
Authors:
Ruoslahti, E
Citation: E. Ruoslahti, Targeting tumor vasculature with homing peptides from phage display, SEM CANC B, 10(6), 2000, pp. 435-442
Authors:
Zisch, AH
Pazzagli, C
Freeman, AL
Schneller, M
Hadman, M
Smith, JW
Ruoslahti, E
Pasquale, EB
Citation: Ah. Zisch et al., Replacing two conserved tyrosines of the EphB2 receptor with glutamic acidprevents binding of SH2 domains without abrogating kinase activity and biological responses, ONCOGENE, 19(2), 2000, pp. 177-187
Authors:
Ruoslahti, E
Rajotte, D
Citation: E. Ruoslahti et D. Rajotte, An address system in the vasculature of normal tissues and tumors, ANN R IMMUN, 18, 2000, pp. 813-827
Authors:
Tellier, MC
Greco, G
Klotman, M
Mosoian, A
Cara, A
Arap, W
Ruoslahti, E
Pasqualini, R
Schnapp, LM
Citation: Mc. Tellier et al., Superfibronectin, a multimeric form of fibronectin, increases HIV infection of primary CD4(+) T lymphocytes, J IMMUNOL, 164(6), 2000, pp. 3236-3245
Authors:
Wang, BC
Zou, JX
Ek-Rylander, B
Ruoslahti, E
Citation: Bc. Wang et al., R-Ras contains a proline-rich site that binds to SH3 domains and is required for integrin activation by R-Ras, J BIOL CHEM, 275(7), 2000, pp. 5222-5227
Authors:
Borges, E
Jan, YW
Ruoslahti, E
Citation: E. Borges et al., Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta(3) integrin through its extracellulardomain, J BIOL CHEM, 275(51), 2000, pp. 39867-39873
Authors:
Pasqualini, R
Koivunen, E
Kain, R
Lahdenranta, J
Sakamoto, M
Stryhn, A
Ashmun, RA
Shapiro, LH
Arap, W
Ruoslahti, E
Citation: R. Pasqualini et al., Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis, CANCER RES, 60(3), 2000, pp. 722-727
Authors:
Fukuda, MN
Ohyama, C
Lowitz, K
Matsuo, O
Pasqualini, R
Ruoslahti, E
Fukuda, M
Citation: Mn. Fukuda et al., A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells, CANCER RES, 60(2), 2000, pp. 450-456
Authors:
Werr, J
Johansson, J
Eriksson, EE
Hedqvist, P
Ruoslahti, E
Lindbom, L
Citation: J. Werr et al., Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue, BLOOD, 95(5), 2000, pp. 1804-1809
Authors:
Vuori, K
Ruoslahti, E
Citation: K. Vuori et E. Ruoslahti, Connections count in cell migration, NAT CELL BI, 1(4), 1999, pp. E85-E87
Authors:
Koivunen, E
Arap, W
Valtanen, H
Rainisalo, A
Medina, OP
Heikkila, P
Kantor, C
Gahmberg, CG
Salo, T
Konttinen, YT
Sorsa, T
Ruoslahti, E
Pasqualini, R
Citation: E. Koivunen et al., Tumor targeting with a selective gelatinase inhibitor, NAT BIOTECH, 17(8), 1999, pp. 768-774
Authors:
Ellerby, HM
Arap, W
Ellerby, LM
Kain, R
Andrusiak, R
Del Rio, G
Krajewski, S
Lombardo, CR
Rao, R
Ruoslahti, E
Bredesen, DE
Pasqualini, R
Citation: Hm. Ellerby et al., Anti-cancer activity of targeted pro-apoptotic peptides, NAT MED, 5(9), 1999, pp. 1032-1038
Authors:
Ruoslahti, E
Citation: E. Ruoslahti, Fibronectin and its integrin receptors in cancer, ADV CANC R, 76, 1999, pp. 1-20
Authors:
Giancotti, FG
Ruoslahti, E
Citation: Fg. Giancotti et E. Ruoslahti, Transduction - Integrin signaling, SCIENCE, 285(5430), 1999, pp. 1028-1032
Authors:
Ruoslahti, E
Reed, J
Citation: E. Ruoslahti et J. Reed, Cell adhesion - New way to activate caspases, NATURE, 397(6719), 1999, pp. 479-480
Authors:
Zou, JX
Wang, BC
Kalo, MS
Zisch, AH
Pasquale, EB
Ruoslahti, E
Citation: Jx. Zou et al., An Eph receptor regulates integrin activity through R-Ras, P NAS US, 96(24), 1999, pp. 13813-13818
Authors:
Rajotte, D
Ruoslahti, E
Citation: D. Rajotte et E. Ruoslahti, Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display, J BIOL CHEM, 274(17), 1999, pp. 11593-11598
Authors:
Miura, R
Aspberg, A
Ethell, IM
Hagihara, K
Schnaar, RL
Ruoslahti, E
Yamaguchi, Y
Citation: R. Miura et al., The proteoglycan lectin domain binds sulfated cell surface glycolipids andpromotes cell adhesion, J BIOL CHEM, 274(16), 1999, pp. 11431-11438
Authors:
Burg, MA
Pasqualini, R
Arap, W
Ruoslahti, E
Stallcup, WB
Citation: Ma. Burg et al., NG2 proteoglycan-binding peptides target tumor neovasculature, CANCER RES, 59(12), 1999, pp. 2869-2874
Authors:
Wang, BC
Yang, HZ
Liu, YC
Jelinek, T
Zhang, LX
Ruoslahti, E
Fu, H
Citation: Bc. Wang et al., Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phagedisplay, BIOCHEM, 38(38), 1999, pp. 12499-12504
Risultati:
1-25
|